Interestingly, study revealed that roflumilast-induced upregulation of PDE4D expression works in concert with IFN-α, and amplifying the antiproliferative action of IFN-α on bladder cancer cells in vitro and vivo (107). This evidence concerns the gene PDE4D and urinary bladder carcinoma.